中国神经再生研究(英文版) ›› 2023, Vol. 18 ›› Issue (6): 1321-1324.doi: 10.4103/1673-5374.357907

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

携带抗原肌球蛋白4分子的探针可用于早期诊断脑缺血再灌注损伤

  

  • 出版日期:2023-06-15 发布日期:2023-01-05
  • 基金资助:
    中国国家自然科学基金项目(81730050)

A molecular probe carrying anti-tropomyosin 4 for early diagnosis of cerebral ischemia/reperfusion injury

Teng-Fei Yu1, Kun Wang2, Lu Yin1, Wen-Zhe Li3, Chuan-Ping Li4, Wei Zhang1, Jie Tian2, 5, *, Wen He1, *   

  1. 1Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 2CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China; 3State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China; 4Anhui Province Key Laboratory of Functional Coordinated Complexes for Materials Chemistry and Application, School of Chemical and Environmental Engineering, Anhui Polytechnic University, Wuhu, Anhui Province, China; 5Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, China
  • Online:2023-06-15 Published:2023-01-05
  • Contact: Wen He, MS, hewen@bjtth.org; Jie Tian, PhD, jie.tian@ia.ac.cn.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, No. 81730050 (to WH).

摘要:

由于脑缺血再灌注损伤的体内示踪仍具有挑战性,因此,实验设计了携带抗原肌球蛋白4分子探针的多孔Ag/Au@SiO2双金属中空纳米壳作为分子探针。经尾静脉注射标记脑缺血再灌注损伤小鼠后,利用超声系统光声成像观察小鼠大脑微血管的变化。结果可见患侧总光声信号强度显著高于健侧;且在再灌注12 h时,患侧血流灌注相对值增加,脑血管损伤加重,抗原肌球蛋白4表达增加;而24h后,患侧血流灌注相对值缓慢下降;1周后趋于稳定,脑损伤缓解。进一步苏木精-伊红和免疫组化染色也证实了脑组织的损伤变化情况。这一结果显示,携带抗原肌球蛋白4分子的探针,可作为一种脑缺血再灌注损伤的早期诊断以及进展评估的新工具。

https://orcid.org/0000-0002-1452-3529 (Teng-Fei Yu)

关键词: font-family:宋体, ">脑缺血再灌注损伤, 原肌球蛋白font-family:Calibri, sans-serif, ">4font-family:宋体, ">, 分子探针, 纳米壳, 光声成像, 诊断, 动态监测, 缺血性脑卒中, 超声, 大脑中动脉闭塞

Abstract: In vivo imaging of cerebral ischemia/reperfusion injury remains an important challenge. We injected porous Ag/Au@SiO2 bimetallic hollow nanoshells carrying anti-tropomyosin 4 as a molecular probe into mice with cerebral ischemia/reperfusion injury and observed microvascular changes in the brain using photoacoustic imaging with ultrasonography. At each measured time point, the total photoacoustic signal was significantly higher on the affected side than on the healthy side. Twelve hours after reperfusion, cerebral perfusion on the affected side increased, cerebrovascular injury worsened, and anti-tropomyosin 4 expression increased. Twenty-four hours after reperfusion and later, perfusion on the affected side declined slowly and stabilized after 1 week; brain injury was also alleviated. Histopathological and immunohistochemical examinations confirmed the brain injury tissue changes. The nanoshell molecular probe carrying anti-tropomyosin 4 has potential for use in early diagnosis of cerebral ischemia/reperfusion injury and evaluating its progression. 

Key words: cerebral ischemia/reperfusion injury, diagnosis, dynamic monitoring, ischemic stroke, middle cerebral artery occlusion, molecular probe, nanoshells, photoacoustic imaging, tropomyosin 4, ultrasound